[
    {
        "text": "hey everyone welcome to the drive podcast i'm your host peter etia hello peter hey bob how are you man i'm doing well how are you i'm great okay you ready for an ama i am i i saw the i saw the agenda it's it's very aggressive yeah yeah ambitious i like it yes yep to say the least i don't know if we'll get through everything um but we did get a lot of follow-up questions on cgm based on our previous section i think it was the previous ama where we talked about glucose we talked about mean glucose glucose variability and glucose spikes and then we also had that sunday email on cgm and non-diabetics it was related to a jama perspective talking about it so there's a bunch of questions on that okay we also have a couple of questions on aura the sleep wearable the aura ring we've got some exercise related questions and we may work in one or two additional questions if we have time how does that sound i think it sounds like a good good list okay so peter since we have a lot of these cgm related questions um one of the things that i've heard you talk about is you have a framework for interventions that i think will be really helpful in laying the foundation for how you think about cgm um and their use in different populations so can you start off by telling us a little bit about that framework yeah so again it doesn't pertain to to cgm specifically it pertains to anything that that comes across my plate but um uh and then the first",
        "start": "00:00:02",
        "duration": 200.638,
        "title": "173 - AMA #26 [sneak peek]: ﻿Continuous glucose monitors, zone 2, & a framework for interventions"
    },
    {
        "text": "time i actually contemplated this was really when i started kind of trying to look critically at the data around meditation so this was probably about uh maybe eight to ten years ago but anyway it basically asks a series of questions so the first question is what is the risk of harm from doing this thing so that's a direct question so if you do x how high is the probability of harm um the second question is obviously the contrapositive of that if you do x what is the probability of benefit um and then the third question and by the way before i go to the third question those first two questions are so obvious that they're almost not worth stating and of course that's mirrored in the way the fda organizes drug trials right so a drug trial is organized first by well after you get through the pre-clinical data the animal work you know after the ind has been filed your first trial in humans which is called a phase one trial is looking at harm i mean it's a it's typically a small trial with dose escalation um that is only trying to understand if as you escalate the dose do you see an increase in side effects very occasionally you see some benefits in a phase one trial and if you do that's interesting but you generally can't take it to the bank because the study is so small uh and generally it's quite homogeneous so that's when you move on to phase two studies which are geared towards efficacy i.e is this thing doing good and of course if the phase two trial is positive you move to a much larger trial called a phase 3 trial",
        "start": "00:01:47",
        "duration": 209.44100000000003,
        "title": "173 - AMA #26 [sneak peek]: ﻿Continuous glucose monitors, zone 2, & a framework for interventions"
    },
    {
        "text": "which really doubles down on efficacy of course both of these trials will continue to be able to pick up any signal of harm so you're always in the spirit of trying to capture that but the real point here is um you're you're you're raising the bar so to speak for what you're demanding of this so again um what's the risk of harm what's that what's the probability of of benefit are two obvious questions i think the third question then is what's the opportunity cost of this intervention and um i i i feel like i've talked about this on a previous podcast before and maybe it was even one of ours but um there was this device sort of a it was a device that you would listen to and it would supposedly put you in a trance and um you know the company that was was proposing this thing had all sorts of theoretical benefits from using it you know if you listen to this device you are less likely to get breast cancer and all of these other things so was there any harm in this device as far as i could tell no i really didn't think that listening to this device was was harmful in any way was there any benefit of this device certainly not to the extent that they made claims that said i had tried the device because a friend of mine bought it for me and i have to admit it was the most relaxing thing i'd ever done in fact virtually every time i tried it i fell asleep so you know maybe there was some good in that maybe there was some bad in that if it was a daytime nap and you could speak to the disadvantages of daytime mapping",
        "start": "00:03:32",
        "duration": 204.55999999999992,
        "title": "173 - AMA #26 [sneak peek]: ﻿Continuous glucose monitors, zone 2, & a framework for interventions"
    },
    {
        "text": "but there was an opportunity cost to it and i don't just mean financial so the device was pretty expensive i want to say it was like a thousand bucks if you were going to buy the thing a thousand bucks is no trivial sum of money for anyone so that's obviously something that has to be weighed against what else could be done with an opportunity cost but the other thing you have to keep in mind is their prescription for use was two 20-minute sessions a day uh much along the lines of um like transcendental meditation which is uh similar but has much better data and that's where i i kind of thought well there's a problem because for most people who are super busy 40 minutes a day for very questionable benefit didn't make a lot of sense if it came at the expense of other things that undoubtedly had benefit such as could that be 40 minutes a day of actual meditation could that be 40 additional minutes a day of sleep could that be 40 minutes a day of exercise all things that i would point to as having far greater evidence in favor of so i think anytime you're thinking about doing something you want to kind of go through that and those are especially important questions to be asking when the answer is not readily apparent from rcts that have generally already answered one and two now remember many rcts you know are the easiest rcts to do are the ones that are based on pharmacology and they're generally addressing one and two but they're not really addressing three because there really isn't much of an opportunity cost of taking a pill outside of the economic cost but the the",
        "start": "00:05:14",
        "duration": 208.959,
        "title": "173 - AMA #26 [sneak peek]: ﻿Continuous glucose monitors, zone 2, & a framework for interventions"
    },
    {
        "text": "time cost of it is is relatively low of course when it comes to rcts that are more intervention based such as exercise yes you you know you want to be able to think about this but as you look to something like cgm in the case of non-diabetics this framework to me is very helpful because at this time we don't have great rcts to point to that say in people who are not yet diabetic there is a benefit to using cgm so again as you go through that you ask yourself the question what is the risk of harm and again when we talk about cgm specifically i think the risk of harm is very low um if we were gonna if we were gonna sort of speculate what could be harmful about it well i think the most obvious thing that comes to my mind is uh anxiety that it can stoke right it can create obsession in in someone and certainly i can speak to that personally i don't think personally i've found it harmful but i could absolutely understand that and i frankly think we have some patience in whom i've never recommended it so for example we have some patients who have a history of eating disorders these are patients i would not in any way shape or form advocate the use of cgm i think it's yet another tool that can create a negative cycle around obsession um is there any chance of it doing good well i mean i think i've already made the case for that i think there's ample chance for it doing good in on two fronts right the first front is what i call insight based good which is teaching you what your carbohydrate",
        "start": "00:06:57",
        "duration": 199.441,
        "title": "173 - AMA #26 [sneak peek]: ﻿Continuous glucose monitors, zone 2, & a framework for interventions"
    },
    {
        "text": "tolerance is that's what the tool is for and then secondly what i would call behavioral good or behavior modification which is effectively a a strapped-on version of the hawthorne effect so when you're wearing a cgm you're basically utilizing a tool that is monitoring you and there is no shortage of data to support to to support the idea that when people are asked to monitor food intake they make changes in the right direction so if i said to you bob you know i want you to record everything you eat for the next month and track it in a food diary are you going to make better food choices than you are making now and the answer is unequivocally yes you are going to do that which is also you know not to pile on i guess this first time i'm mentioning observational epidemiology so far at least for this episode but that's one of the challenges right there with you know food frequency questionnaires is that they start asking them to you know ask them what foods they're eating or they ask them what foods they ate and oftentimes just that by asking they're changing their behavior and so you're not really getting an accurate representation of what they ate previously right so that's a problem that that plagues epidemiology but you can use that to your advantage right so you know and we do that stuff clinically right this is how you create accountability for patients you say look we're going to check in once a day and i just want you to tell me what you ate",
        "start": "00:08:37",
        "duration": 185.68000000000004,
        "title": "173 - AMA #26 [sneak peek]: ﻿Continuous glucose monitors, zone 2, & a framework for interventions"
    },
    {
        "text": "and and even if you provide no other instruction which is oh i want you to have this many grams of protein and this many grams of carbs and this many grams of fat no no even if you don't go to that level if you just say i just want you to tell me what you ate that level of accountability immediately changes a person's behavior and that's an example of how you can use that to your benefit um so if i is that sort of a well i guess i'll get to the third point which is opportunity cost so what's the opportunity cost of one of these devices well i think hands down the biggest opportunity cost is the economic cost these things are not cheap and if you are not diabetic you are not going to have your insurance company cover one of these devices so there are no shortage of companies out there that are repurposing and repackaging cgm so there are really three companies that make cgms in the clinical grade so there's medtronic abbott and dexcom and again by way of full disclosure i consult with dexcom not on their cgm business but actually on a part of their business that deals with other analytes so other things that you could measure so actually don't really interact much on the cgm side but those three companies make cgms and then there are lots of companies like levels and super sapiens that people have heard of who are you know plugging in those cgms into their apps to help um you know users with their goals be it weight loss or otherwise well they're not cheap um i'm trying to remember what the cost is the monthly i mean i feel like the daily cost of cgm is about 10 bucks",
        "start": "00:10:10",
        "duration": 199.91999999999996,
        "title": "173 - AMA #26 [sneak peek]: ﻿Continuous glucose monitors, zone 2, & a framework for interventions"
    },
    {
        "text": "so and there's probably cheaper ways to get it if you're buying your cgm on ebay or if it's a little bit expired but directionally speaking it's about a ten dollar a day habit um and that that adds up right but that's you know call it thirty five hundred dollars a year that's a that's a huge expense assuming you need it every minute of every day and i don't think you do i think you can gain a lot of insight using these things periodically i don't think this is something you need to be tethered to every minute of every day there are some people like me who enjoy that not gonna lie i've been wearing cgm for almost six years it never gets old to me i continue to find insights that you know just provide value and more than anything else it's really the behavioral tool and that might make me a mental  i might just be a guy that is such a simple plebe that having that little cgm on my arm is what keeps me away from the ice cream in the freezer and the cookies in the pantry but if you saw my freezer and you saw my pantry you would certainly understand why i stand to benefit from using cgm well i think i think you mentioned this in the the article or the the sunday post about how the percentages change with when you talk about how much insight you're getting say in the first 30 days versus long term whether it's a motivational or behavioral tool and how those can shift but i also want to mention that when i was at uvm i was getting my undergrad and i was studying nutrition that uh to your point about ice cream in the in the freezer i remember for one of our courses that",
        "start": "00:11:50",
        "duration": 177.76,
        "title": "173 - AMA #26 [sneak peek]: ﻿Continuous glucose monitors, zone 2, & a framework for interventions"
    },
    {
        "text": "we were taking we started doing a food logger food diary and i remember at the time i was eating i don't know why i got into this but i actually you probably will know why i was eating a pint of ben and jerry's chocolate chip cookie dough just religiously every like i would the one that's this big like the little one is that a pint that's it's your the 16 ouncer yeah but i think that's the only thing that ben and jerry's comes in okay okay and you were eating one of those a day i was eating one of those a day after dinner and it was just like a yeah whatever kind of habit i i had to then i was doing the food log and i had to keep a food log and that's how i kicked that like if you want to call it a habit that's how i kick the ben and jerry's habit i said look i'm gonna have to write you know for the i think it's two days during the week and one day during the weekend that i had to do it and that's typically what they do for food diaries and you just log everything you eat you know real time um over 24 hours for like a monday and a thursday and a saturday and i remember i i kicked that habit but it just it reminds me of this stuff that some of these things are behavioral tools maybe in disguise but yeah i think they mentioned something like 90 10. yeah yeah and that's sort of what i tell patients because like a lot of our patients are like hey peter what do you think i mean do you do you think i should do this and my answer for most of them is yeah i think you should i think everybody deserves a three-month trial of cgm again notwithstanding a handful of patients who i think have contraindications and i typically say look it's going to start out as about 90",
        "start": "00:13:20",
        "duration": 175.75900000000004,
        "title": "173 - AMA #26 [sneak peek]: ﻿Continuous glucose monitors, zone 2, & a framework for interventions"
    },
    {
        "text": "10. 90 of this is going to be insight like you're going to be going holy cow i can't believe fill in the blank and only 10 of it is going to be changing your behavior through this hawthorne effect i said by the end of that 90 days that's going to flip again it depends on how much insight you look to extract um but directionally within about three months you're gonna be like you know what i sort of figured out the effect of grapes um and the difference between like you know a grapefruit and a banana like i've i've kind of got that dialed and i've also figured out that you know i can eat a ton of carbs after i work out but if i eat a ton of carbs before bed totally different effect on my blood glucose and then over the overnight and in the morning but the shift is you start to gamify it a little bit uh so yeah again i i guess that's sort of what i would say on on my framework for how to think about these things okay so related questions to cgm i've got actually you just mentioned grapes so this this person says my glucose spikes when i eat some fruits but not others do you know why this happens and does it mean that i should avoid fruits that spike my glucose thank you for listening to today's sneak peek ama episode of the drive if you're interested in hearing the complete version of this ama you'll want to become a member we created a membership program to bring you more in-depth exclusive content without relying on paid ads",
        "start": "00:14:47",
        "duration": 183.99999999999997,
        "title": "173 - AMA #26 [sneak peek]: ﻿Continuous glucose monitors, zone 2, & a framework for interventions"
    },
    {
        "text": "membership benefits are many and beyond the complete episodes of the ama each month they include the following ridiculously comprehensive podcast show notes that detail every topic paper person and thing we discuss on each episode of the drive access to our private podcast feed the qualis which are a super short podcast typically less than five minutes released every tuesday through friday which highlight the best questions topics and tactics discussed on previous episodes of the drive this particularly important for those of you who haven't heard all of the back episodes becomes a great way to go back and filter and decide which ones you want to listen to in detail really steep discount codes for products i use and believe in but for which i don't get paid to endorse and benefits that we continue to add over time if you want to learn more and access these member-only benefits head over to peteratiammd.com forward slash subscribe lastly if you're already a member but you're hearing this it means you haven't downloaded our member-only podcast feed where you can get the full access to the ama and you don't have to listen to this you can download that at peteratiamd.com forward slash members you can find me on twitter instagram and facebook all with the id peteratiammd you can also leave us a review on apple podcast or whatever podcast player you listen on this podcast is for general informational purposes only does not constitute the practice of medicine nursing or other professional health care services including the giving of medical advice",
        "start": "00:16:19",
        "duration": 185.361,
        "title": "173 - AMA #26 [sneak peek]: ﻿Continuous glucose monitors, zone 2, & a framework for interventions"
    },
    {
        "text": "no doctor-patient relationship is formed the use of this information and the materials linked to this podcast is at the user's own risk the content on this podcast is not intended to be a substitute for professional medical advice diagnosis or treatment users should not disregard or delay in obtaining medical advice from any medical condition they have and they should seek the assistance of their healthcare professionals for any such conditions finally i take conflicts of interest very seriously for all of my disclosures and the companies i invest in or advise please visit peteratiammd.com forward slash about where i keep an up-to-date and active list of such companies [Music] [Music] you",
        "start": "00:17:52",
        "duration": 118.86999999999999,
        "title": "173 - AMA #26 [sneak peek]: ﻿Continuous glucose monitors, zone 2, & a framework for interventions"
    }
]